Protea Biosciences Story Overview

PRGB -- USA Stock  

USD 0.04  0.00  0.00%

Macroaxis does not monitor all media channels or aggregates social signals for Protea Biosciences. But even though we do not provide professional-grade financial sentiment analysis on Protea Biosciences G, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Protea Biosciences. Additionally take a look at Protea Biosciences Hype Analysis, Protea Biosciences Correlation and Protea Biosciences Performance.
Purchase by Stanley Hostler of 163923 shares of Protea Biosciences
Filed transaction by Protea Biosciences Group director. General open market or private purchase of non-derivative or derivative security

Protea Biosciences Group Inc insider trading alert for perchase of common stock by Stanley Hostler, Vice President and Secretary, on March 8, 2018. This event was filed by Protea Biosciences Group with SEC on 2014-02-13. Statement of changes in beneficial ownership - SEC Form 4. Stanley Hostler is currently serves as vp, secretary, director and member of audit committee of Protea Biosciences G

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Protea Biosciences

Did you try this?

Run Alpha Finder Now
   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Alpha Finder

Current Liabilities

Current Liabilities Comparative Analysis
  Current Liabilities 
      Protea Biosciences Comparables 
Protea Biosciences is currently under evaluation in current liabilities category among related companies. Current Liabilities is company's short term debts. This usually includes obligations that are due within next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Peers

Protea Biosciences Related Equities
VCEL  4.22 %   
0%
55.0%
VBLT  3.70 %   
0%
48.0%
DOVA  0.13 %   
0%
1.0%
DMTX  0.00 %   
0%
0%
DMPI  0.93 %   
12.0%
0%
DRRX  1.36 %   
17.0%
0%
DNLI  1.62 %   
21.0%
0%
NK  1.93 %   
25.0%
0%
DRNA  2.59 %   
33.0%
0%
VBIV  7.67 %   
100.0%
0%
Additionally take a look at Protea Biosciences Hype Analysis, Protea Biosciences Correlation and Protea Biosciences Performance. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.